Mark Friedman

636 total citations
10 papers, 298 citations indexed

About

Mark Friedman is a scholar working on Psychiatry and Mental health, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mark Friedman has authored 10 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 4 papers in Surgery and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Mark Friedman's work include Migraine and Headache Studies (3 papers), Epilepsy research and treatment (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Mark Friedman is often cited by papers focused on Migraine and Headache Studies (3 papers), Epilepsy research and treatment (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Mark Friedman collaborates with scholars based in United States and United Kingdom. Mark Friedman's co-authors include Andrew G. Herzog, Donald L. Schomer, Alan R. Jacobs, Anton E. Coleman, Frank W. Drislane, Pavel Klein, Jeffrey S. Brown, Joseph Menzin, Bernard J. Ransil and Peter J. Neumann and has published in prestigious journals such as Neurology, Annals of Neurology and Headache The Journal of Head and Face Pain.

In The Last Decade

Mark Friedman

9 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Friedman United States	8	228	194	85	41	32	10	298
G A Buscaino Italy	8	224 1.0×	231 1.2×	121 1.4×	40 1.0×	20 0.6×	23	394
Hepsen Mine Serin Türkiye	10	102 0.4×	104 0.5×	33 0.4×	33 0.8×	15 0.5×	34	290
M.A.M. Bomhof Netherlands	5	297 1.3×	98 0.5×	21 0.2×	47 1.1×	111 3.5×	5	343
Monisha Goyal United States	12	150 0.7×	130 0.7×	12 0.1×	72 1.8×	113 3.5×	21	401
George Mawer United Kingdom	9	366 1.6×	462 2.4×	254 3.0×	38 0.9×	9 0.3×	10	579
Noémi Becser Andersen Denmark	9	160 0.7×	147 0.8×	27 0.3×	17 0.4×	6 0.2×	15	260
Maria Sam United States	11	409 1.8×	296 1.5×	210 2.5×	100 2.4×	46 1.4×	17	575
Chiara Bedetti Italy	10	157 0.7×	119 0.6×	11 0.1×	63 1.5×	54 1.7×	18	303
Giulia Chiarle Italy	8	208 0.9×	16 0.1×	43 0.5×	14 0.3×	46 1.4×	11	289
Darcy Raches United States	11	71 0.3×	105 0.5×	20 0.2×	23 0.6×	21 0.7×	25	291

Countries citing papers authored by Mark Friedman

Since Specialization

Citations

This map shows the geographic impact of Mark Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Friedman more than expected).

Fields of papers citing papers by Mark Friedman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Friedman. The network helps show where Mark Friedman may publish in the future.

Co-authorship network of co-authors of Mark Friedman

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Friedman. A scholar is included among the top collaborators of Mark Friedman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Friedman. Mark Friedman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Brown, Jeffrey S., Marcia F.T. Rupnow, Peter J. Neumann, Mark Friedman, & Joseph Menzin. (2006). Cost effectiveness of topiramate in the prevention of migraines in the United States: an update.. PubMed. 19(12). 31–8. 7 indexed citations

Brown, Jeffrey S., et al.. (2006). Cost-Effectiveness of Migraine Prevention: The Case of Topiramate in the UK. Cephalalgia. 26(12). 1473–1482. 18 indexed citations

Brown, Jeffrey S., George Papadopoulos, Peter J. Neumann, et al.. (2005). Cost‐Effectiveness of Topiramate in Migraine Prevention: Results From a Pharmacoeconomic Model of Topiramate Treatment. Headache The Journal of Head and Face Pain. 45(8). 1012–1022. 39 indexed citations

Friedman, Mark, et al.. (2005). An interactive patient data base for intensive care trend analysis. 67. 163–166.

Brown, Jeffrey S., et al.. (2004). ND2 COST-EFFECTIVENESS OF MIGRAINE PREVENTION: RESULTS FROM A MODEL OF TOPIRAMATE TREATMENT. Value in Health. 7(3). 237–237. 3 indexed citations

Herzog, Andrew G., Anton E. Coleman, Alan R. Jacobs, et al.. (2003). Relationship of sexual dysfunction to epilepsy laterality and reproductive hormone levels in women. Epilepsy & Behavior. 4(4). 407–413. 49 indexed citations

Herzog, Andrew G., Anton E. Coleman, Alan R. Jacobs, et al.. (2003). Interictal EEG discharges, reproductive hormones, and menstrual disorders in epilepsy. Annals of Neurology. 54(5). 625–637. 90 indexed citations

Friedman, Mark, Changiz Geula, Gregory L. Holmes, & Andrew G. Herzog. (2002). GnRH-immunoreactive fiber changes with unilateral amygdala-kindled seizures. Epilepsy Research. 52(2). 73–77. 25 indexed citations

Herzog, Andrew G., et al.. (2001). Transcranial Magnetic Stimulation Evidence of a Potential Role for Progesterone in the Modulation of Premenstrual Corticocortical Inhibition in a Woman with Catamenial Seizure Exacerbation. Epilepsy & Behavior. 2(4). 367–369. 21 indexed citations

10.

Herzog, Andrew G. & Mark Friedman. (2001). Menstrual cycle interval and ovulation in women with localization-related epilepsy. Neurology. 57(11). 2133–2135. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact